Risk factors for severe infections include low levels of CD19+ B cells (especially among patients treated with RTX), high levels of serum immunoglobulin M, older age, and kidney involvement at baseline [13, 14], with some studies [14] (but not others [13]) suggesting a correlation between infection risk and baseline disease activity, assessed using the BVAS [13]. This evidence concerns the gene CD19 and infection.